Brown DG, Wilkerson EC, Love WE (March 2015). "A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons". Journal of the American Academy of Dermatology. 72 (3): 524–534. doi:10.1016/j.jaad.2014.10.027. PMID25486915.
Russell TL, Berardi RR, Barnett JL, O'Sullivan TL, Wagner JG, Dressman JB (January 1994). "pH-related changes in the absorption of dipyridamole in the elderly". Pharmaceutical Research. 11 (1): 136–43. doi:10.1023/a:1018918316253. hdl:2027.42/41435. PMID7908130. S2CID12877330.
Derendorf H, VanderMaelen CP, Brickl RS, MacGregor TR, Eisert W (July 2005). "Dipyridamole bioavailability in subjects with reduced gastric acidity". Journal of Clinical Pharmacology. 45 (7): 845–50. doi:10.1177/0091270005276738. PMID15951475. S2CID36579161.
De Schryver EL, Algra A, van Gijn J (July 2007). Algra A (ed.). "Dipyridamole for preventing stroke and other vascular events in patients with vascular disease". The Cochrane Database of Systematic Reviews (3): CD001820. doi:10.1002/14651858.CD001820.pub3. PMID17636684.
Gamboa A, Abraham R, Diedrich A, Shibao C, Paranjape SY, Farley G, Biaggioni I (October 2005). "Role of adenosine and nitric oxide on the mechanisms of action of dipyridamole". Stroke. 36 (10): 2170–5. doi:10.1161/01.STR.0000179044.37760.9d. PMID16141426. S2CID1877425.
handle.net
hdl.handle.net
Russell TL, Berardi RR, Barnett JL, O'Sullivan TL, Wagner JG, Dressman JB (January 1994). "pH-related changes in the absorption of dipyridamole in the elderly". Pharmaceutical Research. 11 (1): 136–43. doi:10.1023/a:1018918316253. hdl:2027.42/41435. PMID7908130. S2CID12877330.
Brown DG, Wilkerson EC, Love WE (March 2015). "A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons". Journal of the American Academy of Dermatology. 72 (3): 524–534. doi:10.1016/j.jaad.2014.10.027. PMID25486915.
Russell TL, Berardi RR, Barnett JL, O'Sullivan TL, Wagner JG, Dressman JB (January 1994). "pH-related changes in the absorption of dipyridamole in the elderly". Pharmaceutical Research. 11 (1): 136–43. doi:10.1023/a:1018918316253. hdl:2027.42/41435. PMID7908130. S2CID12877330.
Derendorf H, VanderMaelen CP, Brickl RS, MacGregor TR, Eisert W (July 2005). "Dipyridamole bioavailability in subjects with reduced gastric acidity". Journal of Clinical Pharmacology. 45 (7): 845–50. doi:10.1177/0091270005276738. PMID15951475. S2CID36579161.
De Schryver EL, Algra A, van Gijn J (July 2007). Algra A (ed.). "Dipyridamole for preventing stroke and other vascular events in patients with vascular disease". The Cochrane Database of Systematic Reviews (3): CD001820. doi:10.1002/14651858.CD001820.pub3. PMID17636684.
Gamboa A, Abraham R, Diedrich A, Shibao C, Paranjape SY, Farley G, Biaggioni I (October 2005). "Role of adenosine and nitric oxide on the mechanisms of action of dipyridamole". Stroke. 36 (10): 2170–5. doi:10.1161/01.STR.0000179044.37760.9d. PMID16141426. S2CID1877425.
Russell TL, Berardi RR, Barnett JL, O'Sullivan TL, Wagner JG, Dressman JB (January 1994). "pH-related changes in the absorption of dipyridamole in the elderly". Pharmaceutical Research. 11 (1): 136–43. doi:10.1023/a:1018918316253. hdl:2027.42/41435. PMID7908130. S2CID12877330.
Derendorf H, VanderMaelen CP, Brickl RS, MacGregor TR, Eisert W (July 2005). "Dipyridamole bioavailability in subjects with reduced gastric acidity". Journal of Clinical Pharmacology. 45 (7): 845–50. doi:10.1177/0091270005276738. PMID15951475. S2CID36579161.
Gamboa A, Abraham R, Diedrich A, Shibao C, Paranjape SY, Farley G, Biaggioni I (October 2005). "Role of adenosine and nitric oxide on the mechanisms of action of dipyridamole". Stroke. 36 (10): 2170–5. doi:10.1161/01.STR.0000179044.37760.9d. PMID16141426. S2CID1877425.